-
Mashup Score: 0Expert on how recent study findings will affect her counseling of patients with OAB - 6 month(s) ago
“Providers can use this information to counsel patients that that initial sticker shock goes away once you stick with that medication,” says Katherine Shapiro, MD.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 5Bladder training for treating overactive bladder in adults - Funada, S - 2023 | Cochrane Library - 6 month(s) ago
Collapse all Expand all Background Overactive bladder (OAB) is a common chronic and bothersome condition. Bladder training is widely prescribed as a first‐line treatment for OAB, but the efficacy has been systematically evaluated for urinary incontinence rather than OAB alone. Objectives To evaluate the benefits and harms of bladder training for treating adults with OAB compared to no…
Source: www.cochranelibrary.comCategories: General Medicine News, Latest HeadlinesTweet-
Although clinical guidelines recommend bladder training to treat #overactivebladder #OAB #frequenturination, there is no review to evaluate the efficacy systematically....until now! 🔎 📚 Cochrane authors looked at the evidence from 15 studies. https://t.co/wjm4fYrzzv
-
-
Mashup Score: 2EP. 11: Setting Treatment Expectations for Patients with OAB Receiving Third-Line Therapies - 6 month(s) ago
Focused discussion on effectively communicating expectations for third-line therapies with patients being treated for OAB.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet-
Experts discuss setting treatment expectations for patients with OAB receiving third-line therapies. #urology #urologist #OAB Watch now: https://t.co/OkYSGUhjv5
-
-
Mashup Score: 1
“When you’re talking about Medicare patients who are on multiple medications, and this is not the only thing that they’re taking, to pay over $100 for 1 medication is sometimes not possible,” says Katherine Shapiro, MD.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet-
Dr. Katherine Shapiro shares findings on coverage and pricing for overactive bladder medications. #urology #urologist #OAB @NYUUrology Watch now: https://t.co/U6QxT3dgoz
-
-
Mashup Score: 0Optimizing outcomes in sacral neuromodulation for overactive bladder - 6 month(s) ago
These findings may help guide decision-making in the initial testing phase of the [sacral neuromodulation] device prior to permanent implant or explant, according to Bradley Gill, MD, of the Cleveland Clinic.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet-
New insights on sacral neuromodulation lead placement: A recent study uncovers factors linked to SNM success in patients with overactive bladder. #urology #urologist #OAB @BradGillMD @CleClinicUro Read more: https://t.co/oPGKambFfK
-
-
Mashup Score: 0Study evaluates costs of overactive bladder medications - 6 month(s) ago
“Our aim overall is to describe Medicare Part D prescription drug coverage and use of prior authorization and step therapy for these medications,” says Katherine Shapiro, MD.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet-
Dr. Katherine Shapiro highlights a study that evaluated the costs associated with overactive bladder medications. #urology #urologist #OAB Watch now: https://t.co/bN2eBuC9Vc
-
-
Mashup Score: 2Phase 2a Trial Results: Promising Gene Therapy for Overactive Bladder - URO-902 Safety and Efficacy Evaluation - Kenneth Peters - 7 month(s) ago
Ken Peters joins Diane Newman to present the results of a Phase 2a trial evaluating the safety and efficacy of URO-902, an investigational gene therapy for overactive bladder. URO-902 is a plasma vector that expresses the alpha subunit of the human BK channel, which reduces bladder overactivity and leads to detrusor relaxation. The trial included women between 40 and 70 years old with urgency…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Phase 2a trial results: Promising gene therapy for #OveractiveBladder - URO-902 safety and efficacy evaluation. @KennethMPeters1 @BeaumontUrology and @DrDianeNewman discuss these results on UroToday > https://t.co/czCJwVimMM @urovant #OAB #BladderHealth https://t.co/J9onOe371u
-
-
Mashup Score: 0Phase 2a Trial Results: Promising Gene Therapy for Overactive Bladder - URO-902 Safety and Efficacy Evaluation - Kenneth Peters - 8 month(s) ago
Ken Peters joins Diane Newman to present the results of a Phase 2a trial evaluating the safety and efficacy of URO-902, an investigational gene therapy for overactive bladder. URO-902 is a plasma vector that expresses the alpha subunit of the human BK channel, which reduces bladder overactivity and leads to detrusor relaxation. The trial included women between 40 and 70 years old with urgency…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Phase 2a trial results: Promising gene therapy for #OveractiveBladder - URO-902 safety and efficacy evaluation. @KennethMPeters1 @BeaumontUrology and @DrDianeNewman discuss these results on UroToday > https://t.co/czCJwVimMM @urovant #OAB #BladderHealth https://t.co/twQcFFlay5
-
-
Mashup Score: 0Anticholinergic Burden in Overactive Bladder Patients - 9 month(s) ago
Join us for a livestream in educational collaboration with American Society of Consultant Pharmacists on the Anticholinergic Burden in Overactive Bladder Pat…
Source: YouTubeCategories: General Medicine News, Latest HeadlinesTweet-
❓ Did you miss our #livestream from last week? We have you covered with a replay! Watch on demand and share your thoughts or questions with us. #OAB 🎦 Watch here. https://t.co/fgUWxCrX6O
-
-
Mashup Score: 2First-in-Human study shows safety, feasibility of UroMonitor - 10 month(s) ago
UroMonitor was developed in response to conventional urodynamics, which have several limitations.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
First-in-Human study shows safety and feasibility of the UroMonitor device for overactive bladder. #urology #urologist #OAB @CleClinicUro Read more: https://t.co/Qh6024LWZf
-
Dr. Katherine Shapiro discusses how recent study findings on access and costs of oral medications for overactive bladder will affect her counseling of patients. #urology #urologist #OAB @NYUUrology Watch now: https://t.co/FfVoLzewYM